Early Detection of Diabetic Peripheral Neuropathy: A Focus on Small Nerve Fibres

Burgess, Jamie ORCID: 0000-0002-7165-6918, Frank, Bernhard, Marshall, Andrew ORCID: 0000-0001-8273-7089, Khalil, Rashaad S, Ponirakis, Georgios, Petropoulos, Ioannis N, Cuthbertson, Daniel J ORCID: 0000-0002-6128-0822, Malik, Rayaz A and Alam, Uazman ORCID: 0000-0002-3190-1122
(2021) Early Detection of Diabetic Peripheral Neuropathy: A Focus on Small Nerve Fibres. DIAGNOSTICS, 11 (2). 165-.

Access the full-text of this item by clicking on the Open Access link.


Diabetic peripheral neuropathy (DPN) is the most common complication of both type 1 and 2 diabetes. As a result, neuropathic pain, diabetic foot ulcers and lower-limb amputations impact drastically on quality of life, contributing to the individual, societal, financial and healthcare burden of diabetes. DPN is diagnosed at a late, often pre-ulcerative stage due to a lack of early systematic screening and the endorsement of monofilament testing which identifies advanced neuropathy only. Compared to the success of the diabetic eye and kidney screening programmes there is clearly an unmet need for an objective reliable biomarker for the detection of early DPN. This article critically appraises research and clinical methods for the diagnosis or screening of early DPN. In brief, functional measures are subjective and are difficult to implement due to technical complexity. Moreover, skin biopsy is invasive, expensive and lacks diagnostic laboratory capacity. Indeed, point-of-care nerve conduction tests are convenient and easy to implement however questions are raised regarding their suitability for use in screening due to the lack of small nerve fibre evaluation. Corneal confocal microscopy (CCM) is a rapid, non-invasive, and reproducible technique to quantify small nerve fibre damage and repair which can be conducted alongside retinopathy screening. CCM identifies early sub-clinical DPN, predicts the development and allows staging of DPN severity. Automated quantification of CCM with AI has enabled enhanced unbiased quantification of small nerve fibres and potentially early diagnosis of DPN. Improved screening tools will prevent and reduce the burden of foot ulceration and amputations with the primary aim of reducing the prevalence of this common microvascular complication.

Item Type: Article
Uncontrolled Keywords: diabetes, neuropathy, peripheral neuropathy, distal sensory polyneuropathy, diabetic neuropathy, diabetic peripheral neuropathy, early detection, screening, diagnostics, point-of-care
Depositing User: Symplectic Admin
Date Deposited: 03 Feb 2021 16:22
Last Modified: 18 Jan 2023 23:01
DOI: 10.3390/diagnostics11020165
Open Access URL: https://doi.org/10.3390/diagnostics11020165
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3115182